Cargando…

Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study

BACKGROUND: The incidence of nontuberculous mycobacterial lung disease (NTM-LD) peaks in middle- and old age groups, coinciding with senescence; thus, chronic infectious diseases can accelerate frailty and worsen mental health in the elderly. In this study, we aimed to compare the prevalence of phys...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kohei, Ito, Yutaka, Yamamoto, Yuki, Kanai, Osamu, Imakita, Takuma, Oi, Issei, Ito, Takanori, Saito, Zentaro, Mio, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632157/
https://www.ncbi.nlm.nih.gov/pubmed/36329435
http://dx.doi.org/10.1186/s12890-022-02206-5
_version_ 1784823971072442368
author Fujita, Kohei
Ito, Yutaka
Yamamoto, Yuki
Kanai, Osamu
Imakita, Takuma
Oi, Issei
Ito, Takanori
Saito, Zentaro
Mio, Tadashi
author_facet Fujita, Kohei
Ito, Yutaka
Yamamoto, Yuki
Kanai, Osamu
Imakita, Takuma
Oi, Issei
Ito, Takanori
Saito, Zentaro
Mio, Tadashi
author_sort Fujita, Kohei
collection PubMed
description BACKGROUND: The incidence of nontuberculous mycobacterial lung disease (NTM-LD) peaks in middle- and old age groups, coinciding with senescence; thus, chronic infectious diseases can accelerate frailty and worsen mental health in the elderly. In this study, we aimed to compare the prevalence of physical and psychiatric frailty between patients with NTM-LD and bronchiectasis (BE). METHODS: The Kihon Checklist Questionnaire (KCQ) was used to assess physical and psychiatric frailties and identify those at risk of requiring care among patients with newly diagnosed NTM-LD and BE. Additionally, the Hospital Anxiety and Depression Scale (HADS) scores and chronic inflammatory biomarkers of the alveolar region (surfactant protein [SP]-A, SP-D, and human cationic antibacterial protein [hCAP]/LL-37) were assessed and compared between NTM-LD and BE patients. RESULTS: There were no significant differences in the background characteristics between the 33 NTM and 36 BE patients recruited. The KCQ revealed that the proportion of frail NTM patients at diagnosis was higher than that of frail BE patients (48.5% vs. 22.2%, p = 0.026). HADS scores were significantly higher in the NTM group than in the BE group (p < 0.01). Bronchoalveolar lavage fluid (BALF) hCAP/LL-37 and SP-D levels were significantly higher (p = 0.001), but serum hCAP/LL-37 levels were significantly lower in the NTM group than in the BE group (p = 0.023). However, there were no significant differences in the BALF and serum SP-D levels between the two groups. CONCLUSIONS: The number of frail NTM patients at diagnosis was significantly higher than that of frail BE patients. Biomarker analysis suggested that the former had more localized lung inflammation than the latter. TRIAL REGISTRATION: This trial was prospectively registered in the Clinical Trials Registry (UMIN 000027652). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-02206-5.
format Online
Article
Text
id pubmed-9632157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96321572022-11-04 Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study Fujita, Kohei Ito, Yutaka Yamamoto, Yuki Kanai, Osamu Imakita, Takuma Oi, Issei Ito, Takanori Saito, Zentaro Mio, Tadashi BMC Pulm Med Research BACKGROUND: The incidence of nontuberculous mycobacterial lung disease (NTM-LD) peaks in middle- and old age groups, coinciding with senescence; thus, chronic infectious diseases can accelerate frailty and worsen mental health in the elderly. In this study, we aimed to compare the prevalence of physical and psychiatric frailty between patients with NTM-LD and bronchiectasis (BE). METHODS: The Kihon Checklist Questionnaire (KCQ) was used to assess physical and psychiatric frailties and identify those at risk of requiring care among patients with newly diagnosed NTM-LD and BE. Additionally, the Hospital Anxiety and Depression Scale (HADS) scores and chronic inflammatory biomarkers of the alveolar region (surfactant protein [SP]-A, SP-D, and human cationic antibacterial protein [hCAP]/LL-37) were assessed and compared between NTM-LD and BE patients. RESULTS: There were no significant differences in the background characteristics between the 33 NTM and 36 BE patients recruited. The KCQ revealed that the proportion of frail NTM patients at diagnosis was higher than that of frail BE patients (48.5% vs. 22.2%, p = 0.026). HADS scores were significantly higher in the NTM group than in the BE group (p < 0.01). Bronchoalveolar lavage fluid (BALF) hCAP/LL-37 and SP-D levels were significantly higher (p = 0.001), but serum hCAP/LL-37 levels were significantly lower in the NTM group than in the BE group (p = 0.023). However, there were no significant differences in the BALF and serum SP-D levels between the two groups. CONCLUSIONS: The number of frail NTM patients at diagnosis was significantly higher than that of frail BE patients. Biomarker analysis suggested that the former had more localized lung inflammation than the latter. TRIAL REGISTRATION: This trial was prospectively registered in the Clinical Trials Registry (UMIN 000027652). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-022-02206-5. BioMed Central 2022-11-03 /pmc/articles/PMC9632157/ /pubmed/36329435 http://dx.doi.org/10.1186/s12890-022-02206-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fujita, Kohei
Ito, Yutaka
Yamamoto, Yuki
Kanai, Osamu
Imakita, Takuma
Oi, Issei
Ito, Takanori
Saito, Zentaro
Mio, Tadashi
Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
title Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
title_full Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
title_fullStr Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
title_full_unstemmed Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
title_short Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
title_sort comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632157/
https://www.ncbi.nlm.nih.gov/pubmed/36329435
http://dx.doi.org/10.1186/s12890-022-02206-5
work_keys_str_mv AT fujitakohei comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT itoyutaka comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT yamamotoyuki comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT kanaiosamu comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT imakitatakuma comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT oiissei comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT itotakanori comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT saitozentaro comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy
AT miotadashi comparisonoffrailtyinpatientswithnontuberculousmycobacteriallungdiseaseandbronchiectasisaprospectivecohortstudy